NYSE

Dillard's, Inc. (DDS)

508 Thanks from members

Dillard's Q2 2026 earnings beat expectations through margin expansion, low leverage, and a significant one-time tariff refund, masking modest core retail revenue growth.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →